éå»1ã¶æéã«Enanta Pharmaceuticals Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã6åã«åºã¥ãããŒã¿ã
仿ãENTAã¯4ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããENTAã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯22.400ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q3ã«çºè¡šãããEPS -0.670ã«ç¶ããENTAã®FY2026Q4ã®EPSã¯-0.783ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -0.67 ã§ããããEnanta Pharmaceuticals IncENTA ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.45 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -0.78 ãšäºæ³ãããŸãã